1-20 of 158
Leah Lawrence
Close
Sort by
News

Dexamethasone-Sparing Regimen Effective for Older, Frail Patients with NDMM

Free
Leah Lawrence
Published: 2025
Abstract
January 2026
View News titled, Dexamethasone-Sparing Regimen Effective for Older, Frail Patients with NDMM
News

Cancer-Specific Risk Assessment Model Better at Predicting Hospital-Acquired VTE

Free
Leah Lawrence
Published: 2025
Abstract
December 2025
View News titled, Cancer-Specific Risk Assessment Model Better at Predicting Hospital-Acquired VTE
News

Antibody-Based Doublet Effective in Elderly Patients with NDMM

Free
Leah Lawrence
Published: 2025
Abstract
December 2025
View News titled, Antibody-Based Doublet Effective in Elderly Patients with NDMM
News

Fixed-Duration Mosunetuzumab with Lenalidomide Has Benefits for Untreated Indolent Lymphomas

Free
Leah Lawrence
Published: 2025
Abstract
December 2025
View News titled, Fixed-Duration Mosunetuzumab with Lenalidomide Has Benefits for Untreated Indolent Lymphomas
News

Zanubrutinib, Obinutuzumab, Sonrotoclax Combo Shows Positive Outcomes for Treatment-Naïve CLL

Free
Leah Lawrence
Published: 2025
Abstract
December 2025
View News titled, Zanubrutinib, Obinutuzumab, Sonrotoclax Combo Shows Positive Outcomes for Treatment-Naïve CLL
News

Fully Human BCMA-Targeting CAR T-Cell Therapy Eque-Cel May Be Effective in High-Risk NDMM

Free
Leah Lawrence
Published: 2025
Abstract
December 2025
View News titled, Fully Human BCMA-Targeting CAR T-Cell Therapy Eque-Cel May Be Effective in High-Risk NDMM
News

Patient-Clinician Treatment Priorities Don’t Always Align in PV Management

Free
Leah Lawrence
Published: 2025
Abstract
December 2025
View News titled, Patient-Clinician Treatment Priorities Don’t Always Align in PV Management
News

Lower MM Disease Burden Linked With Improved PFS, Safety After BCMA-Targeting CAR-T

Free
Leah Lawrence
Published: 2025
Abstract
December 2025
View News titled, Lower MM Disease Burden Linked With Improved PFS, Safety After BCMA-Targeting CAR-T
News

Education Session Tackles Important Questions Relevant to the Changing Face of CML

Free
Leah Lawrence
Published: 2025
Abstract
Mid-November 2025
View News titled, Education Session Tackles Important Questions Relevant to the Changing Face of CML
News

New Analysis Identifies Predictors of Durable 15-Year PFS in Real-World Analysis of MM

Free
Leah Lawrence
Published: 2025
Abstract
November 2025
View News titled, New Analysis Identifies Predictors of Durable 15-Year PFS in Real-World Analysis of MM
News

FLAG-IDA Plus Venetoclax Performs Well in Children, AYA with Newly Diagnosed AML

Free
Leah Lawrence
Published: 2025
Abstract
November 2025
View News titled, FLAG-IDA Plus Venetoclax Performs Well in Children, AYA with Newly Diagnosed AML
News

p53 IHC Testing May Be Reliable Surrogate for Early Identification of TP53-Mutated MDS, AML

Free
Leah Lawrence
Published: 2025
Abstract
October 2025
View News titled, p53 IHC Testing May Be Reliable Surrogate for Early Identification of TP53-Mutated MDS, AML
News

A Place for Patient Organizations

Free
Leah Lawrence
Published: 2025
Abstract
September 2025 Patient organizations connect physicians with a community that benefits from their expertise, and they offer patients the education and support they need to navigate a hematologic diagnosis.
View News titled, A Place for Patient Organizations
News

Use of ACR/EULAR 2023 Criteria Results in Lower APS Diagnosis Rate Compared With Sydney Criteria

Free
Leah Lawrence
Published: 2025
Abstract
August 2025
View News titled, Use of ACR/EULAR 2023 Criteria Results in Lower APS Diagnosis Rate Compared With Sydney Criteria
News

Menin Inhibitor Revumenib Yields Clinically Meaningful Responses in R/R NPM1-Mutated AML

Free
Leah Lawrence
Published: 2025
Abstract
August 2025
View News titled, Menin Inhibitor Revumenib Yields Clinically Meaningful Responses in R/R NPM1-Mutated AML
News

Caplacizumab Combo a ‘Historic’ New Option for Non-Severe iTTP

Free
Leah Lawrence
Published: 2025
Abstract
August 2025
View News titled, Caplacizumab Combo a ‘Historic’ New Option for Non-Severe iTTP
News

Is Combination Therapy Warranted in Myelofibrosis?

Free
Leah Lawrence
Published: 2025
Abstract
August 2025
View News titled, Is Combination Therapy Warranted in Myelofibrosis?
News

Gene Therapy: Will Slow and Steady Win the Race?

Free
Leah Lawrence
Published: 2025
Abstract
August 2025 Despite decades of work, gene therapy is struggling to gain traction, but researchers continue to pursue breakthrough treatments.
View News titled, Gene Therapy: Will Slow and Steady Win the Race?
News

Patients With CMML Show Durable Response to Lenzilumab, Azacitidine Combo

Free
Leah Lawrence
Published: 2025
Abstract
July 2025
View News titled, Patients With CMML Show Durable Response to Lenzilumab, Azacitidine Combo
News

R-Pola-Glo Shows High Response Rates in Unfit, Older Patients With DLBCL

Free
Leah Lawrence
Published: 2025
Abstract
July 2025
View News titled, R-Pola-Glo Shows High Response Rates in Unfit, Older Patients With DLBCL